Home/Ibex Biosciences/Vidal F. de la Cruz, Ph.D.
VF

Vidal F. de la Cruz, Ph.D.

Chief Scientific Officer, CSO and Cofounder

Ibex Biosciences

Ibex Biosciences Pipeline

DrugIndicationPhase
Antibody Programs (Malaria)MalariaPre-clinical
Antibody Programs (Oncology/Inflammatory)Oncology, Inflammatory ConditionsPre-clinical
CD147 Antibody/ADCOncologyPre-clinical
Regenerative Medicine PlatformUnspecifiedPre-clinical
Gene Therapy ProgramsUnspecifiedPre-clinical